Comparison
Total Raised: --
Fundraising not disclosed
FDV: --
Token not listed
24h Trading Volume: --
Token not listed
Project Name
Intro
--
Total Raised
--
Core Team
--
Core Investors
--
RD Growth Index (7d %)

--
RD Popularity Index (7d %)
--
Details
Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Rate Tharimmune
Rated by 0 users

What’s your take on Tharimmune? Share your review.
Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.
Similar Projects
The Ether Machine
Ethereum Yield and Infrastructure Company(Nasdaq:ETHM)
Fold
Bitcoin Financial Services Company(NASDAQ: FLD)
Quantum Solutions
AI technology listed company(TSE: 2338.T)
Tron Inc
Design and development company(Nasdaq:SRM)
DV8 Public Company Limited
Advertising Media(SET:DV8)


